Sequentia Blockchain Protocol

1. Introduction

1.1 The Problem

The genomics revolution has created an unprecedented data ownership crisis:

• Lack of Sovereignty: Patients surrender ownership of their genomic data to laboratories, research institutions, and pharmaceutical companies without mechanisms for ongoing control or compensation.
• Fragmented Consent: Traditional consent models are binary (yes/no) and cannot adapt to evolving research contexts, derivative analyses, or commercial applications.
• IP Attribution Gap: When genomic data contributes to drug discovery, diagnostic tools, or AI training datasets, the original data donors receive no attribution or financial benefit.
• GDPR Compliance Burden: Healthcare providers struggle to implement Article 17 "Right to Erasure" and Article 20 "Right to Data Portability" for genomic data stored in centralized databases.

1.2 The Sequentia Solution

2. Technical Architecture

2.1 Network Specifications

2.2 Node Architecture

2.3 Storage Architecture

Sequentia implements a hybrid storage model optimized for healthcare data compliance:

3. Consensus Mechanism

3.1 Tendermint Byzantine Fault Tolerance

Sequentia uses Tendermint BFT consensus with the following properties:

• Safety: Guaranteed finality - once a block is committed, it cannot be reverted
• Liveness: Network continues operating as long as >2/3 of validators are honest
• Performance: 5-second block times with instant finality (no need for multiple confirmations)

3.2 Validator Requirements

4. Smart Contract Ecosystem

4.1 BioCIDRegistry (Universal Identifier System)

// Manages unique cryptographic identifiers for biological samples
contract BioCIDRegistry {
    struct BioCID {
        bytes32 fingerprintHash;  // Bloom filter of genomic variants
        address owner;             // Wallet controlling access
        uint256 timestamp;         // Minting date
        string sampleType;         // WGS, WES, RNA-seq, etc.
    }

    mapping(bytes32 => BioCID) public biocids;

    function mintBioCID(
        bytes32 _fingerprintHash,
        string memory _sampleType
    ) external returns (bytes32 biocidId);
}

4.2 BioNFTFactory (Biosample Tokenization)

// ERC-1155 multi-token standard for genomic data assets
contract BioNFTFactory is ERC1155 {
    struct BioAsset {
        bytes32 biocid;            // Links to BioCIDRegistry
        string s3PathEncrypted;    // Encrypted storage location
        uint256 licenseTermsId;    // BioPIL license template
        address[] authorizedLabs;  // Approved data processors
        bool consentActive;        // Can be revoked by owner
    }

    mapping(uint256 => BioAsset) public bioAssets;

    function mintBioNFT(
        bytes32 _biocid,
        string memory _encryptedS3Path,
        uint256 _licenseTermsId
    ) external returns (uint256 tokenId);

    function revokeConsent(uint256 _tokenId) external;
}

4.3 BioPIL (Biological Programmable IP License)

// Genomic data licensing with revenue sharing
contract BioPIL {
    enum LicenseType {
        NonCommercialResearch,      // Academic use only
        ClinicalDiagnostics,        // Hospital/lab testing
        PharmaceuticalR&D,          // Drug discovery
        AITraining,                 // Machine learning datasets
        CommercialDerivatives,      // Consumer genomics apps
        FamilyInheritance          // Automatic heir licensing
    }

    struct LicenseTerms {
        LicenseType licenseType;
        uint256 royaltyBasisPoints;  // e.g., 500 = 5%
        address payable beneficiary; // Data donor or estate
        bool sublicensable;
        uint256 expirationTimestamp;
    }

    mapping(uint256 => LicenseTerms) public pilTemplates;

    function attachLicenseTerms(
        uint256 _bioNftId,
        uint256 _pilTemplateId
    ) external;

    function mintLicenseToken(
        uint256 _bioNftId,
        address _licensee,
        bytes32 _consentHash
    ) external payable returns (uint256 licenseTokenId);
}

5. BioCID Universal Identifier System

5.1 Cryptographic Fingerprinting

BioCID creates collision-resistant identifiers for biological samples without storing raw genomic data on-chain:

# Pseudocode for BioCID generation
def generate_biocid(vcf_file):
    # Extract high-impact variants (MAF < 0.01, CADD > 15)
    rare_variants = filter_variants(vcf_file, maf_threshold=0.01)

    # Create Bloom filter (probabilistic set membership)
    bloom = BloomFilter(size=2048, hash_functions=7)
    for variant in rare_variants:
        bloom.add(f"{variant.chrom}:{variant.pos}:{variant.ref}>{variant.alt}")

    # Hash Bloom filter to create BioCID
    biocid = keccak256(bloom.bit_array)
    return biocid

5.2 Properties

• Privacy-Preserving: Bloom filter reveals no specific variants, only statistical signature
• Collision Resistance: 2048-bit fingerprint provides 2²⁰⁴⁸ possible identities
• Deterministic: Same genomic sample always produces same BioCID
• Linkable: Related samples (parent-child) show partial Bloom filter overlap

6. BioNFT Token Standard

6.1 ERC-1155 Multi-Token Implementation

Sequentia extends ERC-1155 with genomic-specific metadata:

{
  "name": "Whole Exome Sequencing - Patient #5505200871400",
  "description": "Clinical-grade WES analysis (150x coverage, 99.8% target at 20x)",
  "image": "ipfs://Qm.../dna_visualization.png",
  "properties": {
    "biocid": "0x7a3f8b2e...",
    "sampleType": "WES",
    "sequencingPlatform": "Illumina NovaSeq 6000",
    "referenceGenome": "GRCh38",
    "coverage": "150x",
    "consentScope": ["ClinicalCare", "AcademicResearch"],
    "licenseTerms": "BioPIL-NonCommercial-v1",
    "storageEncrypted": true,
    "gdprCompliant": true
  },
  "files": [
    {
      "type": "VCF",
      "format": "gzip",
      "size": "2.3GB",
      "s3PathEncrypted": "AES256:U2Fsd...kZXI=",
      "sha256": "a3f8b2e7c1d..."
    }
  ]
}

6.2 Metamorphosis Journey

7. BioPIL: Genomic IP Licensing Framework

7.1 License Template Library

7.2 Programmable Royalty Streams

Drug Company licenses trio genomic data (father, mother, child)
├─ 60% → Child's wallet (primary data donor)
├─ 20% → Father's wallet (contributed paternal genome)
└─ 20% → Mother's wallet (contributed maternal genome)

8. GDPR Compliance Architecture

8.1 Right to Erasure (Article 17)

Challenge: Blockchain immutability conflicts with data deletion requirements.

8.2 Right to Data Portability (Article 20)

Patients can export data in machine-readable formats:

# GenoBank API call with wallet signature
curl -X GET "https://genobank.app/export_biodata" \
  -H "Authorization: 0x5f5a60..." \
  --output genomic_data_export.zip

# Export contains:
# ├── vcf_files/
# │   ├── biosample_55052008714000.vcf.gz
# │   └── annotation_report.csv
# ├── consent_history.json
# ├── license_tokens.json
# └── royalty_transactions.csv

8.3 Consent Auditing

event DataAccessed(
    uint256 indexed bioNftId,
    address indexed accessor,
    string purpose,
    uint256 timestamp,
    bytes32 consentHashAtTime
);

9. Tokenomics

9.1 SEQ Token Utility

9.2 Token Distribution

9.3 Inflationary Model

• Year 1-5: 5% annual inflation (validator rewards)
• Year 6-10: 3% annual inflation
• Year 11+: 1% annual inflation (long-term sustainability)

10. Network Security

10.1 Validator Slashing Conditions

10.2 DDoS Protection

10.3 Smart Contract Security

All core protocol contracts undergo:

1. Formal Verification: Mathematical proofs of correctness (Certora, K Framework)
2. Multi-Signature Upgrades: 5-of-7 multisig required for contract changes
3. Bug Bounty Program: Up to 100,000 SEQ for critical vulnerabilities
4. Audit Trail: All contract deployments logged with deployer identity

11. Interoperability

11.1 Cross-Chain Bridges

11.2 API Compatibility

// Web3.js - Standard Ethereum tooling works natively
const Web3 = require('web3');
const web3 = new Web3('https://rpc.sequentia.network');

const bioNFT = new web3.eth.Contract(BioNFT_ABI, CONTRACT_ADDRESS);
const balance = await bioNFT.methods.balanceOf(walletAddress, tokenId).call();

12. Roadmap

Phase 1: Genesis Launch (Q4 2024) ✅

• ✅ Mainnet deployment (Chain ID 262144)
• ✅ BioCIDRegistry smart contract
• ✅ BioNFT minting infrastructure
• ✅ Validator onboarding (permissioned set)

Phase 2: DeFi Integration (Q1 2025)

• BioPIL license marketplace
• Automated royalty distribution
• SEQ/USD liquidity pools (Uniswap V3)
• Governance token launch

Phase 3: Institutional Adoption (Q2 2025)

• Hospital system integrations (5+ health networks)
• Pharmaceutical partnership program
• HIPAA-compliant node operator certification
• Academic research consortium (100+ universities)

Phase 4: Global Expansion (Q3-Q4 2025)

• Multi-language support (10+ languages)
• Regional compliance modules (FDA, EMA, PMDA)
• Consumer genomics integration (23andMe, Ancestry.com)
• AI training dataset marketplace

Phase 5: Decentralization (2026)

• Open validator set (permissionless staking)
• On-chain governance (SEQ token voting)
• Cross-chain bridges to 5+ blockchains
• 1M+ patient wallets created

13. Conclusion

Technical Specifications Summary

References

1. European Parliament. (2016). General Data Protection Regulation (GDPR). EUR-Lex.
2. Nakamoto, S. (2008). Bitcoin: A Peer-to-Peer Electronic Cash System.
3. Wood, G. (2014). Ethereum: A Secure Decentralised Generalised Transaction Ledger.
4. Buchman, E. (2016). Tendermint: Byzantine Fault Tolerance in the Age of Blockchains.
5. Story Protocol. (2024). Programmable IP License Framework.
6. NIH. (2024). All of Us Research Program - Genomic Data Sharing Guidelines.
7. FDA. (2023). Guidance for Industry: Use of Electronic Health Records in Clinical Investigations.